Clinical Trial: Medication Development in Alcoholism: Investigating PPAR Agonists

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Medication Development in Alcoholism: Investigating PPAR Agonists

Brief Summary: The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.

Detailed Summary:
Sponsor: The Scripps Research Institute

Current Primary Outcome: Craving to Drink [ Time Frame: 9 days ]

Craving scores on the Visual Analog Scale


Original Primary Outcome: Same as current

Current Secondary Outcome: Drinking Measured by Timeline Follow Back Interview [ Time Frame: 4 weeks ]

Original Secondary Outcome: Same as current

Information By: The Scripps Research Institute

Dates:
Date Received: May 28, 2014
Date Started: May 2014
Date Completion:
Last Updated: December 7, 2016
Last Verified: December 2016